23767-27-3

Basic information

• Product Name: N'-(4-chloro-benzoyl)-hydrazinecarboxylic acid ethyl ester
• CAS NO: 23767-27-3
• Molecular Weight: 242.662
• Mol File: 23767-27-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N'-(4-chloro-benzoyl)-hydrazinecarboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N'-(4-chloro-benzoyl)-hydrazinecarboxylic acid ethyl ester(23767-27-3)
• EPA Substance Registry System: N'-(4-chloro-benzoyl)-hydrazinecarboxylic acid ethyl ester(23767-27-3)

Safety Data

• Hazardous Substances Data: 23767-27-3(Hazardous Substances Data)

Upstream product

• 541-41-3 chloroformic acid ethyl ester 
• 536-40-3 4-chlorobenzoic acid hydrazide 
• 74-11-3 para-chlorobenzoic acid 
• 4231-70-3 p-chlorobenzoyl-1H-1,2,3-benzotriazole 
• 4114-31-2 ethylhydrazine carboxylate 

Downstream Products

• 3206-34-6 2-(4-chlorophenyl)-5-ethoxy-1,3,4-oxadiazole 
• 1711-61-1 5-(4-chlorophenyl)-3H-[1,3,4]oxadiazol-2-one 
• 23766-15-6 benzyl-[5-(4-chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-amine 
• 23766-14-5 2-anilino-5-(4-chlorophenyl)-1,3,4-oxadiazole 
• 90736-28-0 2-chloro-5-(4-chloro-phenyl)-[1,3,4]oxadiazole 

Relevant articles and documents

Synthesis and In Vitro Anticancer Activity of Novel 1,3,4-Oxadiazole-Linked 1,2,3-Triazole/Isoxazole Hybrids

A series of new 1,3,4-oxadiazole-linked 1,2,3-triazole/isoxazole derivatives were designed and synthesized. All the synthesized compounds were screened for in vitro anticancer activity against four human cancer cells: HeLa (cervical), MDA-MB-231 (breast), DU-145 (prostate), and HEPG2 (liver). Among 17 compounds tested, 7a, 7c, and 7d showed potent activity toward four cell lines.